Forte Biosciences Inc
NASDAQ:FBRX
Forte Biosciences Inc
NASDAQ:FBRX
Price:
25.58
USD
2.9%
Market Closed
Market Cap:
$320.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
A
|
AIA Engineering Ltd
NSE:AIAENG
|
IN |
|
Me Today Ltd
NZX:MEE
|
NZ |
|
H
|
Hokushin Co Ltd
TSE:7897
|
JP |
|
Axis Technologies Group Inc
OTC:AXTG
|
US |
|
Z
|
Zhejiang Guanghua Technology Co Ltd
SZSE:001333
|
CN |
|
ASE Technology Holding Co Ltd
NYSE:ASX
|
TW |
|
Kotobuki Spirits Co Ltd
TSE:2222
|
JP |
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
T
|
Tangshan Sunfar Silicon Industries Co Ltd
SSE:603938
|
CN |
|
P
|
Papyrus Australia Ltd
ASX:PPY
|
AU |
|
Iren SpA
OTC:IRDEF
|
IT |
|
Aib Group PLC
F:A5G
|
IE |
|
M
|
MAS Real Estate Inc
JSE:MSP
|
IM |
|
Blue Sphere Corp
OTC:BLSP
|
US |
|
DL Construction Co Ltd
KRX:001880
|
KR |
|
Interactive Brokers Group Inc
NASDAQ:IBKR
|
US |
|
Nexans SA
OTC:NXPRF
|
FR |
|
Nishi-Nippon Railroad Co Ltd
TSE:9031
|
JP |
|
X
|
XL Fleet Corp
F:XLF
|
US |
|
Hillgrove Resources Ltd
ASX:HGO
|
AU |
|
G
|
Garuda Metalindo Tbk PT
IDX:BOLT
|
ID |
|
Brunello Cucinelli SpA
OTC:BCUCF
|
IT |
|
M
|
Merafe Resources Ltd
JSE:MRF
|
ZA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of FBRX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FBRX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
FBRX Competitors Multiples
Forte Biosciences Inc Competitors
Forte Biosciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
320.4m USD | 0 | -6.2 | -4.3 | -4.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
